UnitedHealth Group Incorporated (NYSE:UNH) is Rockland Trust Co.’s 9th Largest Position

Rockland Trust Co. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the third quarter, Holdings Channel reports. The fund owned 77,981 shares of the healthcare conglomerate’s stock after selling 119 shares during the quarter. UnitedHealth Group makes up approximately 2.2% of Rockland Trust Co.’s investment portfolio, making the stock its 9th biggest position. Rockland Trust Co.’s holdings in UnitedHealth Group were worth $45,594,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of UNH. CFS Investment Advisory Services LLC increased its holdings in shares of UnitedHealth Group by 55.0% during the 4th quarter. CFS Investment Advisory Services LLC now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,453,000 after buying an additional 979 shares during the last quarter. CenterBook Partners LP increased its position in UnitedHealth Group by 69.6% during the 4th quarter. CenterBook Partners LP now owns 11,749 shares of the healthcare conglomerate’s stock worth $6,185,000 after purchasing an additional 4,821 shares in the last quarter. AdvisorShares Investments LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $416,000. Delaney Dennis R boosted its position in UnitedHealth Group by 13.0% during the 4th quarter. Delaney Dennis R now owns 8,051 shares of the healthcare conglomerate’s stock worth $4,239,000 after purchasing an additional 925 shares during the period. Finally, Broderick Brian C raised its position in UnitedHealth Group by 4.0% in the fourth quarter. Broderick Brian C now owns 18,607 shares of the healthcare conglomerate’s stock valued at $9,796,000 after purchasing an additional 713 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 0.1 %

NYSE:UNH opened at $592.75 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market capitalization of $547.36 billion, a P/E ratio of 36.23, a P/E/G ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The business has a 50 day simple moving average of $581.82 and a 200 day simple moving average of $526.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $6.14 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Barclays upped their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Truist Financial lifted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.